MedGenome, the largest provider of genomic solutions for populations in South Asia and emerging markets, has raised US$55m Series D funding led by LeapFrog Investments. Existing investors Sofina and Sequoia also participated in the round. The company has now raised US$119m in six rounds according to CrunchBase. “Genomics and personalised medicine are the future of…